Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amide
Cambridge, Massachusetts, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Amide Technologies provides on-demand, high-complexity peptide and polyamide synthesis using a proprietary flow-based manufacturing platform, enabling rapid turnaround (as little as 4 days) and synthesis of peptides up to 120 amino acids—capabilities that exceed standard solid phase peptide synthesis, thus accelerating the development of peptide and protein-based therapeutics[1][2][3][4].
- Modalities
- PeptidesPolyamidesProteins
- Industry
- Drug Discovery Services
02
Partnerships
The Salk InstituteVelia Therapeutics
Beyond the preview
Go deeper on Amide.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amide.